These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 16523927)

  • 1. [Mechanisms for the development and progression of diabetic nephropathy].
    Haneda M
    Nihon Rinsho; 2006 Feb; 64 Suppl 2():427-32. PubMed ID: 16523927
    [No Abstract]   [Full Text] [Related]  

  • 2. [Diabetic nephropathy].
    Sasaki M; Shikata K; Makino H
    Nihon Rinsho; 2006 Sep; Suppl 3():169-74. PubMed ID: 17022524
    [No Abstract]   [Full Text] [Related]  

  • 3. [Molecular understanding of adverse effects of hyperglycemia in diabetic nephropathy].
    Koya D
    Nihon Jinzo Gakkai Shi; 2007; 49(5):470-3. PubMed ID: 17695806
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diabetic nephropathy--predictive methods].
    Ouchi H; Isogai S
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():288-93. PubMed ID: 12430243
    [No Abstract]   [Full Text] [Related]  

  • 5. Mediators of hyperglycemia and the pathogenesis of matrix accumulation in diabetic renal disease.
    Ziyadeh FN
    Miner Electrolyte Metab; 1995; 21(4-5):292-302. PubMed ID: 7565478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression mechanisms and incident factors of diabetic nephropathy].
    Fujita T
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():275-80. PubMed ID: 12430241
    [No Abstract]   [Full Text] [Related]  

  • 7. The pathogenesis of diabetic nephropathy.
    Dronavalli S; Duka I; Bakris GL
    Nat Clin Pract Endocrinol Metab; 2008 Aug; 4(8):444-52. PubMed ID: 18607402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic nephropathy: from mechanisms to rational therapies.
    Giunti S; Barit D; Cooper ME
    Minerva Med; 2006 Jun; 97(3):241-62. PubMed ID: 16855519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Etiology and therapy of diabetic nephropathy].
    Kikkawa R
    Nihon Naika Gakkai Zasshi; 1998 Jul; 87(7):1287-91. PubMed ID: 9745277
    [No Abstract]   [Full Text] [Related]  

  • 10. Suppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195.
    Tsuchida K; Makita Z; Yamagishi S; Atsumi T; Miyoshi H; Obara S; Ishida M; Ishikawa S; Yasumura K; Koike T
    Diabetologia; 1999 May; 42(5):579-88. PubMed ID: 10333051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of basic fibroblast growth factor (FGF-2) in diabetic nephropathy and mechanisms of its induction by hyperglycemia in human renal fibroblasts.
    Vasko R; Koziolek M; Ikehata M; Rastaldi MP; Jung K; Schmid H; Kretzler M; Müller GA; Strutz F
    Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1452-63. PubMed ID: 19279131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical events and cytokine interactions linking glucose metabolism to the development of diabetic nephropathy.
    Sharma K; Ziyadeh FN
    Semin Nephrol; 1997 Mar; 17(2):80-92. PubMed ID: 9148380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diabetic nephropathies].
    Makino H
    Nihon Jinzo Gakkai Shi; 2007; Suppl 50th Ann():49-66. PubMed ID: 17899828
    [No Abstract]   [Full Text] [Related]  

  • 14. Diabetic nephropathy: important pathophysiologic mechanisms.
    Soldatos G; Cooper ME
    Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S75-9. PubMed ID: 18994672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic role of advanced glycosylation end products in diabetic nephropathy.
    Lee HB; Cha MK; Song KI; KIm JH; Lee EY; Kim SI; Kim J; Yoo MH
    Kidney Int Suppl; 1997 Sep; 60():S60-5. PubMed ID: 9285904
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy.
    Kelly DJ; Buck D; Cox AJ; Zhang Y; Gilbert RE
    Am J Physiol Renal Physiol; 2007 Aug; 293(2):F565-74. PubMed ID: 17522264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Diabetic nephropathies: therapeutic aspects].
    Bulliard C; Fontana E; Ruiz J
    Praxis (Bern 1994); 2001 Dec; 90(51-52):2266-71. PubMed ID: 11820169
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic nephropathy: where hemodynamics meets metabolism.
    Forbes JM; Fukami K; Cooper ME
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Role of hyperglycemia in the development of diabetic microangiopathy].
    Miyata S; Kasuga M
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():45-51. PubMed ID: 15999684
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathophysiology of diabetic nephropathy.
    Sego S
    Nephrol Nurs J; 2007; 34(6):631-3. PubMed ID: 18203571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.